What can metabolites tell us about gliomas?

Affiliations

¹ Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
² Division of Gene Regulation, Cancer Center, Fujita Health University, Toyoake, Japan.

Editorial

Oltea Sampetrean et al. Neuro Oncol. 2022.

. 2022 Sep 1;24(9):1469-1470.

doi: 10.1093/neuonc/noac128.

¹ Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
² Division of Gene Regulation, Cancer Center, Fujita Health University, Toyoake, Japan.

No abstract available

Comment on

Distinct metabolic hallmarks of WHO classified adult glioma subtypes.
Björkblom B, Wibom C, Eriksson M, Bergenheim AT, Sjöberg RL, Jonsson P, Brännström T, Antti H, Sandström M, Melin B. Björkblom B, et al. Neuro Oncol. 2022 Sep 1;24(9):1454-1468. doi: 10.1093/neuonc/noac042. Neuro Oncol. 2022. PMID: 35157758 Free PMC article.

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. - PubMed
1. Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31–46. - PubMed
1. Dang L, White DW, Gross S, et al. . Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462(7274):739–744. - PMC - PubMed
1. Liu X, Locasale JW. Metabolomics: a primer. Trends Biochem Sci. 2017;42(4):274–284. - PMC - PubMed
1. Björkblom B, Wibom C, Eriksson M, et al. . Distinct metabolic hallmarks of WHO classified adult glioma subtypes. Neuro Oncol. 2022;24(9):1454–1468. - PMC - PubMed